Pfizer's EPS has been on a rollercoaster ride in recent years. As of the latest data in Q4 2023, the company experienced a loss of $0.6 per share. However, taking a look at the multi-year data, we can see a significant increase in EPS from 2020 to 2021, jumping from $0.15 to $0.6. Despite the recent loss, it's important to consider the overall trend and the potential for future growth.